Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Monsenso ASOCSE:MONSO +4.57%29 Days Payable is 40.97 as of Dec. 2025, which is 6% above its 10-year median of 38.56. GuruFocus rates OCSE:MONSO with a GF Score™ of 29/100 and a GF Value™ of kr0.15 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 607 Healthcare Providers & Services companies, Monsenso AS ranks worse than 68.37% on this metric.
The historical rank and industry rank for Monsenso AS's Days Payable or its related term are showing as below:
OCSE:MONSO'
s Days Payable Range Over the Past 10 Years
Min: 20.72 Med: 38.56 Max: 124.11
Current: 35.26
During the past 9 years, Monsenso AS's highest Days Payable was 124.11. The lowest was 20.72. And the median was 38.56.
OCSE:MONSO's Days Payable is ranked worse than 68.37% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 57.13
vs OCSE:MONSO: 35.26
Monsenso AS's Days Payable
increased
from Dec. 2024 (26.61) to Dec. 2025 (40.97).
It may suggest that Monsenso ASdelayed paying its suppliers.
Monsenso AS Days Payable Related Terms
Monsenso AS Days Payable Historical Data
* Premium members only.
The historical data trend for Monsenso AS's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OCSE:MONSO vs VEEV, BTSG, TEM: Days Payable Comparison
For the Health Information Services subindustry, Monsenso AS's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Monsenso AS Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Monsenso AS's Days Payable distribution charts can be found below:
* The bar in red indicates where Monsenso AS's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Monsenso AS's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Monsenso AS (OCSE:MONSO) has a Days Payable of 40.97 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Monsenso AS and its competitors. This is near median its historical median of 38.56. Over the past decade, Monsenso AS's Days Payable has ranged from 20.72 to 124.11. According to the industry distribution chart, Monsenso AS ranks #415 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 68.4%.
Is Monsenso AS's Days Payable too high?
Monsenso AS's current Days Payable of 40.97 is near median its 10-year median of 38.56. Over the past 10 years, this metric has ranged from a low of 20.72 to a high of 124.11. The Healthcare Providers & Services industry median Days Payable is 57.13. Monsenso AS's value of 40.97 is 28.3% below this industry median. Based on the distribution chart, Monsenso AS ranks #415 out of 607 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Monsenso AS has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Monsenso AS's Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Monsenso AS ranks #415 out of 607 companies for Days Payable. This places Monsenso AS in the lower half of its industry. The industry median Days Payable is 57.13. Monsenso AS's value of 40.97 is 28.3% below this benchmark. Historically, Monsenso AS's own Days Payable has ranged from 20.72 to 124.11 over the past decade. While the company's 10-year median is 38.56 vs. the industry median of 57.13, Monsenso AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.13, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Monsenso AS's current Days Payable of 40.97 is 28.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Monsenso AS and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Monsenso AS's current Days Payable is 40.97, which is near median its own 10-year median of 38.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Monsenso AS stock overvalued right now?
Based on GuruFocus' analysis, Monsenso AS (OCSE:MONSO) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.15, compared to a current price of kr0.37 — trading 144% above its estimated fair value. The current Days Payable is 40.97, which is near median its 10-year median of 38.56 and 28.3% below the Healthcare Providers & Services industry median of 57.13. Monsenso AS's overall GF Score™ is 29/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Monsenso AS (OCSE:MONSO), the current Days Payable is 40.97 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Monsenso AS (OCSE:MONSO) Overvalued in 2026?
Based on GuruFocus' analysis, Monsenso AS stock appears to be overvalued.
The current stock price of kr0.37 is trading 144% above its estimated GF Value™ of kr0.15.
GuruFocus considers Monsenso AS to be Significantly Overvalued.
Key valuation signals for OCSE:MONSO:
Days Payable: 40.97 (near median its 10-year median of 38.56)
GF Value™: kr0.15 vs. price of kr0.37 (144% above fair value)
Industry Position: 28.3% below the Healthcare Providers & Services median (#415 of 607)
No single metric tells the full story. See the OCSE:MONSO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Monsenso AS is a mobile mental health company. It technology company offering a digital health solution used for decentralized trials, remote patient monitoring, and treatment support. The company's mission is to contribute to improved health for more people at lower costs by supporting treatment digitally and leveraging patient-reported outcomes data, and the solution helps optimise the treatment and gives a detailed overview of an individual's health through the collection of outcome, adherence, and behavioral data.
29GF Score
Get the complete analysis for OCSE:MONSO
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCSE:MONSO has been successfully added to your 
